XOSPATA® (gilteritinib): Learn more about the only FDA-approved therapy for relapsed/refractory FLT3m+ AML
DATE:
Tuesday, November 30, 2021
Arrival: 530 PM
Start: 6:00 PM
LOCATION:
Stoney River
3015 West End Avenue
Nashville, TN
PRESENTED BY:
CONNIE SIZEMORE, PharmD
Lead Clinical Pharmacy Specialist
The Blood & Marrow Transplant Program
Northside Hospital
Atlanta, GA